References
- Chaykin S. Biochemistry Laboratory Techniques. John Wiley and Sons, New York 1966
- Dent J. G., Graichen M. E. Effect of hepatocarcinogens on epoxide hydrolase and other xenobiotic metabolizing enzymes. Carcinogenesis 1982; 13: 733–738
- Ducos P., Maire C., Gawdin R. Assessment of Occupational exposure to 4,4′-methylene-bis-(2-chloroaniline)-MOCA’ by a new sensitive method for biological monitoring. International Archives of Occupational and Environmental Health 1985; 55: 159–167
- Guengerich F. P. Microsomal enzymes involved in toxicology—analysis and separation. Principles and Methods of Toxicology, A. Wallace Hayes. Raven Press, New York 1982; 609–634
- Guengerich F. P., Dannan S. T., Wright S. T., Martin M. V., Kaminsky L. S. Purification and characterization of microsomal cytochrome P-450s. Xenobiotica 1982; 12: 701–716
- Hesbert A., Bottin M. C., Ceaurriz J. D. Mutagenicity of 4,4′-methylene bis(2-chloroaniline)-MOCA’ and its N-acetyl derivatives in S. typhimurium. International Archives of Occupational and Environmental Health 1985; 55: 169–174
- IARC. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. Lyon 1974; Vol. 4: 65–71
- IARC. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. Lyon 1980; Vol. 24: 59–76
- IARC. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. Lyon 1986; Vol 39: 347–365
- Ioannides C., Parke D. V. The cytochromes P-448—a unique family of enzymes involved in chemical toxicity and carcinogenesis. Biochemical Pharmacology 1987; 36: 4197–4207
- Ioannides C., Lum P. Y., Parke D. V. Cytochrome P-448 and the activation of toxic chemicals and carcinogens. Xenobiotica 1984; 14: 119–137
- Kommineni C., Groth D. H., Frockt I. J., Voelker R. W., Stanovick R. P. Determination of the tumorigenic potential of methylene-bis-orthochloroaniline. Journal of Environmental Pathology and Toxicology 1979; 2: 149–171
- Kulkarni A. P., Fabacher D. L., Hodgson E. Pesticide as inducers of hepatic drug metabolizing enzymes—II. Glutathione S-transferases. General Pharmacology 1980; 11: 437–441
- Lamb J. C., Huff J. E., Haseman J. K., Murthy A. S. K., Lilja H. Carcinogenesis studies of 4,4′-methylenedianiline dihydrochloride given in drinking water to F344/N rats and B6C3F1 mice. Journal of Toxicology and Environmental Health 1986; 18: 325–337
- Linch A. L., O'Connor G. B., Barnes J. R., Killian A. S., Neeld W. E. Methylene-bis-ortho-chloroaniline (MOCA): evaluation of hazards and exposure control. American Industrial Hygiene Association Journal 1971; 32: 802–819
- Mazel P. Experiments illustrating drug metabolism in vitro. Fundamentals of Drug Metabolism and Drug Disposition, B. N. La Du, H. G. Mandel, E. L. Way. Williams & Wilkins, Baltimore 1972; 546–582
- Meny B. Carcinogenicity of diaminodiphenyl sulfone(DDS). International Journal of Leprosy 1975; 43: 280–281
- Mori H., Yoshimi N., Sugie S., Iwata H., Kiwai K., Mashizu N., Shimizu H. Genotoxicity of epoxy resin hardeners in the hepatocyte primary culture/DNA repair test. Mutation Research 1988; 204: 638–688
- Omura T., Sato R. The CO binding pigment of liver microsomes. Evidence for its hemoprotein nature. Journal of Biological Chemistry 1964; 239: 2370–2378
- Parke D. V. Control of the expression of genes coding for drug-induced proteins. Survey of drug metabolising enzymes. Biochemical Society Transaction 1983; 11: 457–458
- Parke D. V., Ioannides C. Role of mixed-function oxidases in the formation of biological reactive intermediates. Advances in Experimental Medicine and Biology 1982; 135A: 23–38
- Prough R. A., Burke M. D., Mayer R. T. Direct fluorometric methods for measuring mixed function oxidase activity. Methods in Enzymology, S. Fleischer, L. Packer. Academic Press, New York 1978; Vol. 52C: 372–377
- Rao I. K., Dorsey G. F., Allen B. E., Epler J. L. Mutagenicity of 4,4′-methylenedianiline derivatives in the Salmonella histidine reversion assay. Archives of Toxicology 1982; 49: 185–190
- Reidy G. F., Murray M., Rose H. A., Bonin A. M., Baker R. S. U., Stacey N. H. Identification of the hepatic cytochrome P-450 isozymes induced and decreased by Picloram. Biochemical Pharmacology 1988; 37: 1021–1025
- Russfield A. B., Homburger F., Boger E., Van Dongen C. E., Weisburger E. K., Weisburger J. H. The carcinogenic effect of 4,4′-methylene bis-(2-chloroaniline) in mice and rats. Toxicology and Applied Pharmacology 1975; 31: 47–54
- Stula E. F., Barnes J. R., Sherman H., Reinhardt C. F., Zapp J. A. Urinary bladder tumors in dogs from 4,4′-methylene-bis(2-chloroaniline) (MOCA). Journal of Environmental Pathology and Toxicology 1977; 1: 31–50
- Stula E. F., Sherman H., Zapp J. A., Claycon J. W. Experimental neoplasia in rats from oral administration of 3,3′-dichlorobenzidine, 4,4′-methylene-bis(2-chloroaniline), and 4,4′-methylene-bis(2-methyl aniline). Toxicology and Applied Pharmacology 1975; 31: 159–176
- Szafraniec T. An appraisal of the biological monitoring of 4,4′-methylene-bis(2-chloroaniline) (MOCA): 5 years after regulation. Presented at the Australia New Zealand Environmental Mutagen Society meeting. 1987
- Weisburger E. K., Murthy A. S. K., Lilja H. S., Lamb J. C. Neoplastic response of F334 rats and B6C3F1 mice to the polymer and dyestuff intermediates 4,4′-methylene-bis(N,N-dimethyl)-benzenamine, 4,4′-oxydianiline, and 4,4′-methylenedianiline. Journal of the National Cancer Institute 1984; 72: 1457–1463
- Wolff T., Deml E., Wanders H. Aldrin epoxidation, a highly sensitive indicator specific for cytochrome P-450 dependent monooxygenase activities. Drug Metabolism and Disposition 1979; 7: 301–305